 
        Dr  
        Serdar  
        Uzar  
        
        Dr  
        Serdar  
        Uzar  
        Head of Viral Vaccine Production Laboratory  
        İstanbul Pendik Veterinary Control Institute  
LinkedIn 
View profileBiography
        I have been serving as a veterinarian at the Pendik Veterinary Control Institute since 2011, starting my career in the CApripoxvirus reference diagnosis laboratory. Until 2014, I focused on molecular diagnosis, cell culture isolation, and the molecular analysis of various viral animal diseases. Since then, I have been assigned to the Viral Vaccine Production Laboratory, and for the past six years, I have led this team as the laboratory chief. I hold a Ph.D. in veterinary virology and have contributed to the development of sheep and goat pox vaccines, as well as Parapoxvirus Ovis vaccines. My expertise extends to diagnostic and production efforts related to these diseases. Additionally, I have participated in R&D projects to expand my knowledge. My experience includes vaccine development for Bovine Rotavirus and Coronavirus. During the SARS-CoV-2 pandemic, I took part in one of the vaccine development teams in Turkey, conducting serological studies for inactivated vaccine projects. Currently, I also serve as a technical expert on the Veterinary Immunological Products Commission of the Ministry of Agriculture and Forestry of Turkey. Moreover, I act as a Good Manufacturing Practices (GMP) auditor, overseeing the inspection of veterinary immunological and pharmaceutical product facilities. Throughout my career, I have accumulated extensive experience in the fields mentioned above.  Research interests
        Molecular diagnosis and cell culture isolation of viral animal diseases
R&D in veterinary virology and vaccine development
Good Manufacturing Practices (GMP) auditing for veterinary immunological and pharmaceutical products
Technical expertise in reviewing veterinary immunological product dossiers  Discipline
        Bio-manufacturing      Challenge model development      Challenge study design      Clinical trials – efficacy      Clinical trials – safety      Commercialisation      Formulation technology      Immunology – B-cells      QC test development      Quality assurance      Registration      Regulation      Safety evaluation      Virology  Host species
        Cattle      Small ruminants      Zoonoses  Pathogen
        Viruses      Viruses›Capripoxvirus      Viruses›Coronavirus      Viruses›Peste des petits ruminants virus      Viruses›Poxviruses      Viruses›Rotavirus  Stage of vaccine development
        Adjuvants      Antigen discovery and immunogen design      Clinical trials      Commercialisation      Field trials      Pre-clinical trials